GlucoTrack, Inc.(GCTK)
Health Care Technology
Patient Engagement Software
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% Owner | Purchase | +242,118 | +9.68%2,743,591 | N/A | N/A | View SEC filing | |
| 2025-03-31 | BALLANTYNE JOHN Director, 10% Owner | Purchase | +242,118 | +9.66%2,747,717 | N/A | N/A | View SEC filing | |
| 2025-03-31 | Malave Luis Director | Purchase | +6,411 | +4.67%143,617 | N/A | N/A | View SEC filing | |
| 2025-03-31 | Carter Erin Catherine Director | Purchase | +1,603 | +3.64%45,632 | N/A | N/A | View SEC filing | |
| 2025-03-28 | Goode Paul Chief Executive Officer | Purchase | +2,421 | +14.61%18,989 | N/A | N/A | View SEC filing | |
| 2024-07-03 | SYCOFF DREW Director, 10% Owner | Purchase | +138,000 | +4.91%2,951,257.6 | N/A | N/A | View SEC filing | |
| 2024-07-03 | Goode Paul Chief Executive Officer | Purchase | +42,000 | +11.77%398,819.52 | N/A | N/A | View SEC filing | |
| 2024-04-24 | SYCOFF DREW Director, 10% Owner | Purchase | +182,539.6 | +6.59%2,951,257.6 | $1.26 | $230,000 | View SEC filing | |
| 2017-03-14 | Darivoff Philip Director | Purchase | +666,669 | +100.00%666,669 | N/A | N/A | View SEC filing | |
| 2016-12-02 | Darivoff Philip Director | Purchase | +200,001 | +100.00%200,001 | N/A | N/A | View SEC filing |
1-10 of 10